Medscape Video

{{{header}}}

Young Adults With Type 2 Diabetes: A Journey Begins

Vanderbilt University experts discuss treatment of type 2 diabetes in young adults, examining use of new agents and devices, challenges of adherence, and risks of longer duration of disease exposure.

Better With Age: Improving Breast Cancer Care in Older Adults

Breast cancer experts at Duke and University of North Carolina discuss complexities and challenges in the treatment of older breast cancer patients, and strategies to improve their quality of life.

Alzheimer's Disease: Unraveling the Tangle

Indiana specialists discuss advances that enable earlier diagnosis of Alzheimer's disease as well as new drugs targeting cognitive changes and which patients will benefit most from approved therapies.

Setting the Course: Aligning Expectations in Multiple Sclerosis Treatment

Cleveland Clinic specialists in multiple sclerosis discuss how shared decision-making and a multidisciplinary approach work to align clinical goals with the expectations of their patients.

A Gut Reaction: The Microbiome and Immune Checkpoint Inhibitor Response

Oncologists discuss research into altering the microbiome through fecal transplant or changes in diet to improve tumor response to immune checkpoint inhibitors.

The Long Game: Extending Lung Cancer Survival

Leading thoracic oncologists at Winship Cancer Institute discuss factors that have improved lung cancer treatment and patient survival over the past decade.

Future at Risk: Treating Depression in Young Adults

Alabama mental health experts report on the urgent need to increase screening for depression in young adults and share strategies to improve early diagnosis and provide varied treatment modalities.

Invisible Threat: Prostate Cancer Without Symptoms

Prostate cancer is often asymptomatic at the time of diagnosis, and treatment can affect quality of life more than the disease itself does. In this series, specialists discuss treatment benefit vs risk.

Comorbidities in IPF: Compounding a Heavy Burden

Pulmonologists at Yale School of Medicine explain idiopathic pulmonary fibrosis (IPF); the impact of comorbidities on this incurable, progressive disease; and new directions in drug research.

Providing Equitable Care in Early Breast Cancer

Experts at Mount Sinai in New York City report on groundbreaking advances in early breast cancer therapy and discuss strategies to ensure access to comprehensive breast cancer care for all patients.

Through a Different Lens: Redefining Heart Failure

Leading cardiologists from Northwestern Medicine discuss patient challenges and treatment breakthroughs for persons diagnosed with heart failure with preserved ejection fraction.

Immune Thrombocytopenia: Protecting Endangered Platelets

University of Southern California physicians discuss challenges in diagnosis and individualized management of immune thrombocytopenia (ITP) and report on COVID vaccine precautions for these patients.

Diabetes & Kidney Disease: A Heart in Jeopardy

Top kidney and heart specialists from Indiana University School of Medicine explain how slowing the progression of chronic kidney disease can protect the heart.

An Unwelcome Return: Relapsed/Refractory Non-Hodgkin Lymphomas

Mayo Clinic oncologists discuss the importance of an accurate NHL diagnosis to inform therapy, which includes adding novel targeted agents to standard of care.

Sleepless Nation: A Public Health Epidemic

Leading sleep specialists discuss growing concerns regarding the dangers of insufficient sleep, why sleep disorders are underdiagnosed, and how to help patients get the sleep they need.

Real Progress: Tailored Therapy in Early, High-Risk Breast Cancer

Dr Lisa Carey from the University of North Carolina discusses the integration of newer therapies for high-risk, early breast cancers into clinical therapy and strategies to personalize treatment.

Bispecific Checkpoint Antibodies: A New Type of Combination Therapy

New bispecific checkpoint immunotherapies target multiple checkpoints with a single molecule, and may offer efficacy and toxicity benefits over monotherapy combination treatments.

The Other Epidemic: Type 2 Diabetes and Obesity

Leading experts discuss the increasing prevalence of type 2 diabetes in young adults, which is linked to rising rates in childhood obesity, and offer the latest strategies to slow or reverse disease progression.

Alzheimer's Disease: Hope on the Horizon

Mayo Clinic neurologists explore the devastating effects of Alzheimer's and discuss the scientific advances that led to the approval of the first new therapy for the disease in over 20 years.

Pneumonia in the Shadow of COVID-19

Leading pulmonary specialists from the University of Louisville explain the burden of community-acquired pneumonia in older adults and reflect on complications caused by COVID-19.

Beyond Glucose: Reducing CVD in Patients With Diabetes

University of California cardiologists discuss the importance of managing multiple metabolic factors in diabetes patients to slow progression of CVD. They also share risk-reduction strategies.

A Vulnerable Time: Transitioning to Adulthood With Sickle Cell Disease

Hematologists at Boston Medical Center guide patients with sickle cell disease through the transition from pediatric to adult care, including strategies to ensure medication adherence and manage pain.

Double Trouble: Lung Cancer and Coexisting COPD

COPD and lung cancer are often found in the same patient. In this series, Stanford University experts discuss the link to smoking in both diseases and COPD's effect on lung cancer treatment.

Heart Failure: Fighting for Life

Cardiologists from Stanford University Medical Center discuss management of heart failure, ranging from patients living for decades with the disease to those requiring repeat hospitalizations.

The Gift of Time: Delaying Metastasis in Prostate Cancer

Experts from Cedars-Sinai in Los Angeles explore issues faced by men with nonmetastatic castration-resistant prostate cancer and how next-generation androgen receptor inhibitors are restarting lives.

Air Supply: Targeting Eosinophils in Severe Asthma

Leading pulmonologists discuss how the identification of eosinophilic subtypes has led to improved asthma management and development of new therapies for patients with severe asthma.

A Delicate Balance: Identifying and Treating Pancreatic Cancer

Pancreatic cancer typically presents as late-stage disease, when treatment options are few. In this series, oncologists discuss how germline testing, targeted therapies, and an array of emerging treatment options are poised to improve outcomes in pancreatic cancer.

Jumping Downhill: Acute Exacerbations of IPF

UCSF pulmonologists discuss the challenge of preparing patients for acute exacerbations of IPF and the importance of early recognition of symptoms.

COVID-19: Tracking the Science

Leading epidemiologists explain how the novel coronavirus SARS-CoV-2 causes COVID-19. Virologists describe the all-out race to develop a vaccine. Physicians discuss current treatment guidelines.

Finding Balance: Updates in Treatment for Multiple Sclerosis

Neurologists pivot to virtual consults and question whether to modify standard therapies for patients with MS during the COVID-19 pandemic.

Identifying and Treating ITP

Doctors discuss the signs of immune thrombocytopenia and how the burden of this condition can affect patients and their families.

Launching From an Unstable Platform: Bipolar Depression in Adolescents and Young Adults

Toronto psychiatrists and mental health experts examine the complexities of diagnosis and treatment of bipolar depression in adolescents, and discuss important physical and psychiatric comorbidities.

Beyond the Itch: Managing and Treating Adolescent Atopic Dermatitis

Atopic dermatitis is a chronic, hereditary condition whose effect on children and adolescents extends far beyond the skin. In this series, doctors discuss strategies for managing this disease.

Defining Optimal Therapy in High-Risk Early Breast Cancer

Leading oncologists from Stanford University Medical Center report on optimal therapeutic strategies to prevent recurrence in patients with early, high-risk breast cancer.

Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas

Oncologists from Washington University in St. Louis discuss the diagnosis of rare B-cell non-Hodgkin lymphomas as well as current treatment strategies for both indolent and aggressive subtypes.

Inroads Into Natural Killer Cell Immunotherapy

Oncologists at UCSD and MD Anderson discuss recent advances in immunotherapies using natural killer (NK) cells, including NK checkpoint inhibition and CAR NK chimeric antigen receptor (CAR) NK therapies.

Born Into Pain: Pushing for Progress in Sickle Cell Disease

Leading hematologists from Vanderbilt University discuss the diverse manifestations of sickle cell disease and strategies to manage the complex medical and psychosocial needs of patients.

Early Start: Strategies to Improve Outcomes in IPF

University of Washington pulmonologists discuss diagnostic challenges of idiopathic pulmonary fibrosis (IPF) and how early treatment and personalized management strategies can improve outcomes.

AML: The Next Generation of Tailored Therapy

In acute myeloid leukemia, identifying somatic and germline mutations allows oncologists to better individualize treatment, from targeted therapies to optimal donors for allogeneic transplant.

Cardiovascular Risk Reduction: Protecting the Aging Heart

University of Maryland cardiologists discuss the risk factors for cardiovascular disease in older patients as well as realistic goals and strategies for effective risk reduction.

Room for Optimism: Treating Metastatic NSCLC

Thoracic oncologists at the University of Colorado Cancer Center in Aurora manage patients with stage IV metastatic non-small cell lung cancer under the shadow of COVID-19.

A Persistent Problem: Preventing Heart Failure

Heart failure continues to be a leading cause of morbidity and mortality. In this series, Cardiologists discuss associated burdens of the disease and why identifying risk factors is critical to slowing the epidemic.

Small Steps in Pancreatic Cancer

MD Anderson oncologists discuss recent advances in the understanding of heritable forms of pancreatic cancer and the impact on genetic testing guidelines and screening potential for affected families.

Confronting the HIV Epidemic

Infectious disease experts from UNC Chapel Hill have developed innovative methods to engage young minority men, the fastest-growing HIV-positive population, in the prevention and treatment of HIV.

One Pill Won't Do It: Treating Chronic Pain

Pain specialists at the Cleveland Clinic discuss optimal therapies, opioid alternatives, and lifestyle alterations for treating chronic pain, which affects at least 50 million Americans.

Signal Disruption: Targeted Therapies for CLL

Hematologists from Ohio State University discuss ongoing trials and emerging developments in firstline treatment for chronic lymphocytic leukemia, including targeted and novel combination therapies.

Letting the Light Back In: New Agents for Acute Migraine Attacks

Neurologists from the Jefferson Headache Center discuss new therapeutic agents and devices that may gain control over acute migraine attacks.

Shifting the Target in Ulcerative Colitis

UCSD gastroenterologists discuss the latest developments in the diagnosis and treatment of ulcerative colitis, including the emergence of biologic therapies and new targeted small-molecule drugs.

Reducing Fracture in Postmenopausal Osteoporosis

A leading Chicago endocrinologist emphasizes the importance of early intervention to reduce postmenopausal osteoporotic fracture, including optimal pharmacologic and nonpharmacologic approaches.

Preventing Pain: Managing and Treating Rheumatoid Arthritis

UCLA rheumatologists discuss the latest therapies for rheumatoid arthritis but emphasize the key role that patients play in developing their treatment plans if the best outcomes are to be achieved.

Children With ITP: Navigating an Unpredictable Course

Hematologists at Texas Children's Hospital discuss the variable course of pediatric ITP, the burdens of chronic ITP on children and families, and management strategies of an unpredictable disorder.

Positive Strides in Triple-Negative Breast Cancer

Leading oncologists from Dana-Farber Cancer Institute and UCSF Medical Center report on recent advances in the treatment of triple-negative breast cancer, an aggressive cancer that occurs more frequently in young women.

Plaque Psoriasis: Looking for the 'Off' Switch

Increased understanding of the proinflammatory immune pathway underlying plaque psoriasis has led to the development of biologic therapies that target specific cytokines along that pathway.

Damage Control: Managing Nonalcoholic Steatohepatitis

University of California hepatologists examine the need for increased awareness of nonalcoholic steatohepatitis (NASH) and discuss key risk factors, management strategies, and emerging therapies.

Preventing Relapse: Current Strategies in MS Management

Specialists from the University of Virginia discuss the difficulties in confirming a diagnosis of multiple sclerosis as well as decision-making strategies to prevent disease progression.

New Options in Adult AML

Duke oncologists discuss expanded treatment options for older AML patients, including numerous targeted therapies and less intensive regimens that yield durable remissions and improve quality of life.

Chronic Pain: Pain Without Purpose

Specialists at the Stanford Pain Management Center examine the impact of chronic pain on health, the cycle that can convert acute to chronic pain, and strategies for the management of chronic pain.

Emerging Trends: Targeted Therapy for CLL

MD Anderson hematologists discuss recent developments in treatment options for chronic lymphocytic leukemia, including monoclonal antibodies, targeted therapies, and small-molecule inhibitors.

Start the Conversation: Genitourinary Syndrome of Menopause

Experts in reproductive science from the Women's Health Institute at Rutgers Robert Wood Johnson Medical School discuss the signs, symptoms, and treatment of genitourinary syndrome of menopause.

Chronic Heart Failure: The Myth of the Stable Patient

Cardiologists discuss persistent hospitalization rates and mortality among heart failure patients, despite treatment advances.

Slowing the Clock: Managing Type 2 Diabetes as Patients Age

Leading endocrinologists at Montefiore Medical System in New York City discuss strategies to slow progression of type 2 diabetes and manage age-related comorbidities.

Relapsed Hodgkin: A Second Chance for Success

University of Nebraska hematologists explore treatment options for relapsed/refractory Hodgkin lymphoma and discuss the importance of autologous stem cell transplantation and targeted agents.

Smoldering Multiple Myeloma: Dangerous Precursor

Revised criteria for multiple myeloma and an array of effective, well-tolerated myeloma drugs have prompted hematologists to assess the benefit of treating smoldering multiple myeloma.

Stigmatizing Movement: Strategies in Managing Tardive Dyskinesia

Movement disorder experts at Case Western Reserve University survey strategies for diagnosis of tardive dyskinesia and discuss long-term management in patients with chronic movement disorders.

Immuno-Oncology's Challenge: Overcoming Resistance

Renowned immuno-oncologists at Georgetown-Lombardi discuss the latest research into mechanisms of resistance to checkpoint inhibitors and report on promising strategies to improve anti-tumor response.

Playing the Long Game: Managing Cardiovascular Risk in Young Adults

Notable cardiologists discuss the importance of assessing risk in young adults and convey strategies for long-term risk management for the prevention of atherosclerotic cardiovascular disease.

Moving the Goal Post: Treatment-Free Remission for CML

Experts from Froedtert Hospital and the Medical College of Wisconsin discuss the new paradigm for treating chronic myeloid leukemia as a chronic disease and for assessing patient eligibility for treatment-free remission.

Making Strides: New Approaches to Metastatic Bladder Cancer

Experts from The Tisch Cancer Institute at Mount Sinai in New York City examine the complexities of treating metastatic bladder cancer and the important role that immunotherapy now plays.

Candida auris: A Resistant Fungal Infection

New Jersey infectious disease experts discuss the emerging threat of Candida auris -- the first identified multidrug-resistant fungus -- and the need for increased surveillance.

Staying Golden: Aging With HIV

San Francisco?area infectious disease experts who battled the HIV/AIDS epidemic for decades now address the unique needs and vulnerabilities of patients who are aging with HIV.

Cracking the Code: Targeted Therapies in Lung Cancer

Leading thoracic oncologists in Boston delve into the molecular targets in NSCLC and discuss current management strategies that now must take into account immunotherapy and targeted therapy options.

Extending Response: Treatment Advances in Metastatic Melanoma

Chicago oncologists use the latest immune and targeted therapies to increase survival in metastatic melanoma, and report that the microbiome may hold the key to overcoming resistance to therapy.

Boosting Platelets: Optimal Management of ITP

Hematologists from Massachusetts General Hospital examine the need for up-to-date guidance on the treatment of ITP and offer strategies to sequence medication and individualize treatment decisions.

Not the Usual Suspects: Unforeseen Risks in Osteoporosis

A University of Colorado osteoporosis specialist emphasizes the need for broader screening, especially in overlooked groups such as men, patients taking glucocorticoids, and patients with chronic kidney disease.

Hunger for Air: Management Strategies in IPF

Vanderbilt pulmonologists discuss new therapies for idiopathic pulmonary fibrosis as well as strategies to prolong life through pulmonary rehab, comorbidity management, and oxygen therapy.

Going the Distance With Metastatic Breast Cancer

Experts at Dana-Farber Cancer Institute discuss how targeted agents used in combination with endocrine therapy are extending the lives of women with HR+/HER2- metastatic breast cancer.

Extinguishing Inflammation: Evolving Challenges in IBD

Leading gastroenterologists from the University of California at San Diego delve into the warning signs for IBD and the most current strategies for diagnosing and treating these progressive diseases.

Under New Management: Approaches to Lipid Control

Cardiologists specializing in lipid management as it relates to the prevention of cardiovascular disease discuss factors that can undermine efforts to help a patient reduce cholesterol levels.

Chronic Myeloid Leukemia: Rewriting Frontline Therapy

For 20 years, TKIs have been standard treatment in CML. But a growing number of options, including generic imatinib, raises questions regarding what is optimal frontline therapy for a given patient.

Multiple Myeloma: Options for Better Outcomes

Leading oncologists from the City of Hope Medical Center discuss targeted therapies and immunotherapies, including CAR T cells, that are redefining treatment of patients with relapsed multiple myeloma.

Pressing Need: Improving Management of Chronic Constipation

Michigan gastroenterologists confront multifactorial causes of chronic constipation and discuss the varied management options, from emerging treatments to physical therapy to alternative medicine.

Lung Cancer: Immunotherapy's Expanding Indications

Oncologists at UCLA Medical Center discuss the benefits of immunotherapy alone and in combination with chemotherapy in patients with advanced lung cancer.

Non-Hodgkin Lymphoma: Test-Driving CAR T-Cell Therapy

CAR T-cell therapy is redirecting treatment and redefining the model of care for patients with relapsing lymphoma. The vanguard Moffitt team discusses the issues involved in this breakthrough therapy.

Vanishing Platelets: Issues in Thrombocytopenia

Hematologists from McMaster University in Ontario, Canada, explore the complex issues in the diagnosis and management of thrombocytopenia and ITP.

Asthma Redefined--Managing Multiple Diseases

Pittsburgh asthma experts discuss their approach to addressing the increasing prevalence of severe, adult-onset asthma.

Involuntary Movements: Managing Tardive Dyskinesia

Psychiatric experts discuss the need for early detection of tardive dyskinesia as well as decision-making regarding medication modification in the effort to prevent and manage involuntary movements.

Keeping Pace: Managing Atrial Fibrillation in Athletes

Notable cardiologists specializing in sports medicine and electrophysiology discuss strategies for treating the lifelong endurance athlete who has atrial fibrillation.

Hidden Measures: Uncovering Cardiovascular Risk

Recognized experts in cardiology and preventive medicine discuss their ongoing pursuit of optimal criteria for determining patient risk for cardiovascular disease.

Bladder Cancer: Tracking the Leaders

Unchanged for decades, the management of bladder cancer is experiencing critical advances in surgical approaches, reconstructive options, and a growing array of immunotherapies.

Diabetes and Depression: The One-Two Punch

The interplay between diabetes and depression can complicate the treatment of both conditions, requiring the coordinated efforts of physicians, mental health providers, and patients to nullify this one-two punch.

Dry Eye: A Clinical Focus

Ophthalmologists from Wills Eye Hospital report on the growing incidence of dry eye, reasons why it goes unrecognized, and best practices for diagnosis and treatment of this life-altering syndrome.

Slowing Progression: Management Strategies in COPD

Seattle pulmonary medicine specialists discuss the debilitating effect of COPD and cite how a growing understanding of the disease may improve patient outcomes.

Psoriasis in Pregnancy: Delivering Safe Outcomes

Psoriasis is a chronic autoimmune disease with an average onset age of 28 in women. Onset often coincides with pregnancy, creating discomfort as well as obstacles to treatment.

CVD and Rheumatoid Arthritis: A Dangerous Link

Leading rheumatologists at the University of Colorado discuss the need for careful screening and aggressive risk management for cardiovascular disease in patients with rheumatoid arthritis.

Women and America's HIV Epidemic

Black women in the South are disproportionately represented among new cases of HIV but face barriers to diagnosis and treatment, prompting researchers to dub the trend a silent epidemic.

Waiting to Pounce: When Varicella Returns

NYU Langone Medical Center experts discuss the complex nature of herpes zoster. Often considered straightforward, the diagnosis of herpes zoster may be overlooked and can lead to devastating sequelae.

Precision Nursing: Paradigm Shift in Cancer Care

In the era of precision medicine, oncology nurses are expanding their expertise into genetics and genomics, engaging in translational research, and redefining their time-honored focus on patient care.

Cholesterol, Inflammation, and Cardiovascular Risk

Cardiologists from Brigham and Women's Hospital in Boston discuss changing approaches to managing atherosclerotic cardiovascular risk in primary- and secondary-prevention cases.

Psoriatic Arthritis: An Unwanted Partnership

Experts at the University of Toronto discuss the importance of early diagnosis of psoriatic arthritis, key aspects of evaluation, and appropriate therapeutic strategies.

Meningitis: Preventing a Fatal Infection

Though uncommon in the United States, meningitis can be silent and devastating. Texas infectious disease experts stay on the alert for viral and bacterial infections in high-risk groups.

Hepatitis C Virus: Containing the Threat

HCV treatments are highly efficacious, but challenges remain in screening persons at risk of contracting and spreading infection, as well as in the treatment of liver diseases caused by HCV.

Breathless: When IPF Strikes

Pulmonologists discuss significant improvements being made in the diagnosis and management of idiopathic pulmonary fibrosis, a severe, chronic disease with no cause and no cure.

Personal Best: Individualizing Therapy in Melanoma

Noted oncologist Dr Jeffrey Weber details how the NYU Langone team is individualizing treatment for its metastatic melanoma patients, to allow each a personal best outcome.

Plan of Attack: Navigating Migraine Care

Migraine, one of the most common neurologic conditions, remains underdiagnosed and ill managed. Boston neurologists pioneer novel approaches to treat migraine.

Managing Bacterial Infections

Lyme disease, urinary tract infections, and gastrointestinal infections can pose clinical challenges. Experts report on key aspects in the diagnosis and treatment of these bacterial diseases.

Acute Myeloid Leukemia: Looking for Leftover Disease

A team of New York doctors is changing the course of acute myeloid leukemia by finding and killing cancer cells before the disease can clinically recur, extending remission -- and survival.

Gaining Momentum: New Strategies in Ovarian Cancer

Oncologists at MD Anderson are using innovative clinical trial design to identify effective therapies and improve outcomes in ovarian cancer.

More Than Skin Deep: Issues in Managing Atopic Dermatitis

Dermatologists at Northwestern University tackle the management of severe eczema using advanced medical and alternative treatments, and explore the intriguing relationship between eczemas and allergy.

Multiple Myeloma: A Changing Landscape

Leading oncologists from the Mayo Clinic chart the optimal course through the changing therapeutic landscape of early relapsed multiple myeloma.

Renal Cell Carcinoma: The New Challenge

Two noted oncologists tackle a puzzling clinical question: What is the optimal sequence of therapies for patients with metastatic renal cell carcinoma?

Rapid Progression: Immunotherapy in Lung Cancer

Renowned oncologists from NY-Presbyterian/Columbia University Medical Center discuss the revolutionary impact of immunotherapies for lung cancer as well as the nuances of their use in patient care.

Not on Anyone's Radar: Colorectal Cancer in Young Adults

Why is colorectal cancer on the rise in young adults? Researchers look for answers as oncologists and patients confront a cancer no one expected.

The Unsuspected Killer: Community-Acquired Pneumonia

Pneumonia can strike anyone, from presidential candidates to famous puppeteers. And the number-one cause of death from infectious disease is all too frequently a race against time.

Confronting Insulin

What is the role of insulin in the management of type 2 diabetes? A 5-part series looks at challenges for physicians and patients alike.

{{{header}}}

Targeted Therapies for Soft Tissue Sarcomas

Maintenance Therapy for Urothelial Carcinoma

Early Diagnosis and Treatment in Alzheimer's Disease

Survivorship in Veterans: Prostate Cancer

Lung Fibrosis and Idiopathic Pulmonary Fibrosis

Rapid Symptom Improvement in Major Depressive Disorder

Treating Heart Failure in Patients With T2D and Renal Dysfunction

Diversity, Equity, and Inclusion in Colorectal Cancer Treatment

Combination Therapies for Patients With Type 2 Diabetes

Inherited Retinal Diseases: Early Signs and Treatment

Reducing Hospitalization in Heart Failure

Non-Insulin Treatment Adherence in Type 2 Diabetes

Managing Patients With Obesity and Impaired Renal Function

Obesity Management in Youth-Onset Type 2 Diabetes

Endocrine Therapy Resistance in HR+/HER2- Breast Cancer

Emerging Therapies for Alzheimer's Disease

CAR T-Cell Therapy for Diffuse Large B-Cell Lymphoma

New Therapies for Generalized Pustular Psoriasis

How Mental Health Affects Management of Type 2 Diabetes

Peripheral Neuropathy in Type 2 Diabetes

Managing Type 2 Diabetes in Pediatric Patients

Optimal Use of CDK4/6 Inhibitors in Breast Cancer

Emerging Therapies for Early Alzheimer's Disease

Targeted Agents Plus Endocrine Therapy in HR+/HER2- MBC

Obesity Management in Primary Care

The Psychosocial Burden of Obesity

Primary Care in Diagnosis and Management of IPF

CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

Weight Management and the Well-Woman Exam

Treatment Advances in Wet Age-Related Macular Degeneration

New and Emerging Therapies for HFrEF

Frontline Treatment for Advanced HR+/HER2- Breast Cancer

Addressing Noncognitive Symptoms of Alzheimer's Disease

Optimal Use of Disease-Modifying Therapies in ATTR-CM

New Treatments for Major Depressive Disorder

Clinical Implications of Recent Psoriatic Arthritis Studies

Treatment Intensification in Type 2 Diabetes

Obesity Action Plan for Adults With Type 2 Diabetes

Individualizing Insulin Therapy in Type 2 Diabetes

Antihyperglycemic Therapy in Patients With T2D and Obesity

Atypical EGFR Mutations in Non-Small Cell Lung Cancer

February 17, 2023

Treatment Options for Relapsed/Refractory MCL

February 14, 2023

Reducing Risk of Sudden Coronary Death

February 6, 2023

Management of Heart Failure in Patients With Type 2 Diabetes

January 31, 2023

Best Practices in HR+/HER2- Breast Cancer

January 31, 2023

Improving Outcomes in Mantle Cell Lymphoma

January 31, 2023

Advanced/Metastatic HER2+ Treatment Options and Rationale

January 27, 2023

CD19-Directed CAR-T-Cell Therapy in Relapsed/Refractory BCL

January 17, 2023

Optimal Treatment for Active SLE

January 11, 2023

Treatment Advances in Paroxysmal Nocturnal Hemoglobinuria

{{{header}}}

Alzheimer's Disease Highlights From AAN 2023

Age-Related Macular Degeneration Highlights From ARVO 2023

Advances in Breast Cancer From AACR 2023

Key Takeaways in Early Breast Cancer From AACR 2023

Ovarian Cancer: Key Abstracts From SGO 2023

Endometrial Cancer: Key Abstracts From SGO 2023

Psoriasis Highlights From AAD 2023

Atopic Dermatitis Highlights From AAD 2023

Heart Disease and Diabetes: New Data From ACC/WCC 2023

Key Asthma Abstracts From AAAAI 2023

HIV Treatment and Neurologic Data Highlights From CROI 2023

Key Abstracts in Renal Cell Carcinoma From ASCO GU 2023

February 7, 2023

Highlights From ASCO GI 2023

January 4, 2023

Chronic Lymphocytic Leukemia Highlights From ASH 2022

January 4, 2023

Breakthroughs in Mantle Cell Lymphoma From ASH 2022

January 3, 2023

Key Data in Non-Hodgkin Lymphoma From ASH 2022

January 3, 2023

Highlights in Multiple Myeloma From ASH 2022

December 30, 2022

Advances in CAR-T Cell Therapy From ASH 2022

December 30, 2022

Top Studies in HER2+ Breast Cancer From SABCS 2022

December 29, 2022

Top Studies in Metastatic Breast Cancer From SABCS 2022

December 7, 2022

Highlights in Obesity From ACG 2022

December 6, 2022

Highlights in Breast Cancer From SITC 2022

December 6, 2022

Advances in Non-Small Cell Lung Cancer From SITC 2022

December 5, 2022

Psoriatic Arthritis Highlights From ACR 2022

December 1, 2022

Highlights in Metastatic Kidney Cancer Treatment From IKCS 2022

November 30, 2022

Diabetes and Heart Disease Highlights From AHA 2022

November 29, 2022

Highlights in Diabetes and Metabolism From ASN 2022

November 15, 2022

Advances in Multiple Sclerosis From ECTRIMS 2022

November 15, 2022

Highlights in Esophageal Research From ACG 2022

November 9, 2022

Key Abstracts in COPD From CHEST 2022

November 9, 2022

Highlights in Asthma Therapy From CHEST 2022

October 21, 2022

Highlights in Corneal Disorders From AAO 2022

October 14, 2022

Myasthenia Gravis Highlights From AANEM

October 14, 2022

Updates on Glycemic Control in Type 2 Diabetes From EASD 2022

October 14, 2022

Key Data on Comorbidities in Type 2 Diabetes From EASD 2022

October 12, 2022

Advances in Insulin Therapy for Type 2 Diabetes From EASD 2022

October 5, 2022

Highlights in Advanced NSCLC From ESMO 2022

October 4, 2022

Key Data on Early NSCLC From ESMO 2022

October 3, 2022

Psoriasis Highlights From EADV 2022

October 3, 2022

Atopic Dermatitis Highlights From EADV 2022

September 30, 2022

Updates in Renal Cell Carcinoma From ESMO 2022

September 20, 2022

Updates in Heart Failure From ESC 2022

September 14, 2022

Advances in Diabetes and Heart Disease From ESC 2022

August 24, 2022

Key Abstracts in Dementia Science From AAIC 2022

Multiple Sclerosis Highlights From EAN 2022

Advances in Thrombosis and Hemostasis From EHA 2022

Highlights in Early Breast Cancer From ASCO 2022

Highlights in Renal Cell Carcinoma From ASCO 2022

Key Data on Insulin in Type 2 Diabetes From ADA 2022

Key Studies in Bladder Cancer From ASCO 2022

{{{header}}}

NSCLC e-Tumor Boards: Case 6: NSCLC with Multiple Primaries

Prostate Cancer e-Tumor Boards: Case 5: Favorable Intermediate Risk CaP

NSCLC e-Tumor Boards: Case 5: Squamous Cell Carcinoma with TP53 Mutations

Psoriasis, Psoriatic Arthritis, With Comorbidities

Endometrial Cancer e-Tumor Boards: Case 2: Advanced Stage Recurrent Uterine Cancer

Prostate Cancer e-Tumor Boards: Case 4: Asymptomatic Prostate Adenocarcinoma

Psoriatic Disease With Gastrointestinal Symptoms

Mantle Cell Lymphoma e-Tumor Boards: Case 1: MCL with TP53 Mutation

Endometrial Cancer e-Tumor Boards: Case 1: FIGO Grade 3 Invasive Endometrial Carcinoma

Reducing Lung Function Decline in a Patient With Progressive Fibrosing ILD

Type 2 Diabetes in a Young Adult With Obesity

November 21, 2022

CLL e-Tumor Boards: Case 2: Relapsed Chronic Lymphocytic Leukemia

November 14, 2022

Early Breast Cancer e-Tumor Boards: Case 2: HER2-positive De Novo Metastatic Breast Cancer

November 1, 2022

RCC e-Tumor Boards: Case 3: Non-Clear Cell RCC

October 5, 2022

NSCLC e-Tumor Boards: Case 4: EGFR Mutant NSCLC with Brain Metastasis

September 30, 2022

Colorectal Cancer e-Tumor Boards: Case 3: Defective DNA Mismatch Repair CRC

September 20, 2022

Prostate Cancer e-Tumor Boards: Case 3: Oligometastatic Prostate Cancer

August 11, 2022

Bladder Cancer e-Tumor Boards: Case 3: Metastatic Bladder Cancer

Breast Cancer e-Tumor Boards: Case 3: Advanced Stage III HER2+/HR+ Breast Cancer with Brain Metastasis

CLL e-Tumor Boards: Case 1: Stage II Chronic Lymphocytic Leukemia

Type 2 Diabetes With Chronic Kidney Disease

Exercise and Pulmonary Arterial Hypertension

Bladder Cancer e-Tumor Boards: Case 2: Non-muscle Invasive Bladder Cancer

Prostate Cancer e-Tumor Boards: Case 2: Early Detected, Low-risk Prostate Cancer

RCC e-Tumor Boards: Case 2: High-Risk Localized RCC

Type 2 Diabetes With Obesity

Psoriatic Arthritis With Cardiovascular Disease

Chronic Heart Failure Worsening After Hospitalization

Colorectal Cancer e-Tumor Boards: Case 2: Colorectal Liver Metastases

Treatment-Resistant Major Depressive Disorder

Early Breast Cancer e-Tumor Boards: Case 1: HER2-negative Invasive Ductal Carcinoma

Type 2 Diabetes With ASCVD

Chronic Heart Failure With Reduced Ejection Fraction

Breast Cancer e-Tumor Boards: Case 2: Advanced Unresectable ER+/HER2- Breast Cancer

NSCLC e-Tumor Boards: Case 3: ALK-Rearranged NSCLC with Brain Metastasis

Psoriatic Arthritis With Suspected Enthesitis

January 24, 2022

Prostate Cancer e-Tumor Boards: Case 1: Unfavorable Intermediate-Risk Prostate Cancer

January 3, 2022

Triple Negative Breast Cancer e-Tumor Boards: Case 1: Recurrent Metaplastic Triple Negative Breast Cancer

January 3, 2022

Colorectal Cancer e-Tumor Boards: Case 1: Newly Diagnosed With Moderately Differentiated Rectal Adenocarcinoma

November 18, 2021

NSCLC e-Tumor Boards: Case 2: Spindle Cell NSCLC with Recurrence of Previously Resected Tumor

November 15, 2021

Breast Cancer e-Tumor Boards: Case 1: HR+/HER2- Metastatic Breast Cancer

November 1, 2021

Bladder Cancer e-Tumor Boards: Case 1: Muscle Invasive Bladder Cancer

October 19, 2021

RCC e-Tumor Boards: Case 1: Metastatic Clear Cell Renal Cell Carcinoma

August 30, 2021

NSCLC e-Tumor Boards: Case 1: Stage IV NSCLC with Brain Metastases

{{{header}}}

Racial Disparities in CLL: Underrepresentation in Clinical Trials

A Path to a Career in CLL Clinical Research

Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy

The Costs of Disparities in the Treatment of Chronic Lymphocytic Leukemia

How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia

Learning to Appreciate the Impact of CLL on the Lives of Patients

Taking the Long View in the Treatment of CLL

Cancer Survivorship: The Importance of Encouraging Psychosocial Support

Cancer Survivorship: Treating Every Patient as a Unique Individual

Addressing Patient Concerns in Prostate Cancer

Health Disparities in the Diagnosis and Treatment of Interstitial Lung Disease

In Retrospect: The Evolution of Understanding of Interstitial Lung Disease

Innovative Tools to Help Lessen Disparities for Patients With Interstitial Lung Disease

Lessons Learned From a Mentor in Interstitial Lung Disease

A Patient Experience That Sparked a Career in Interstitial Lung Disease

Establishing Connections in the Management of Interstitial Lung Disease

Accepting Patient Autonomy in the Treatment of Early Breast Cancer

Meeting an Unmet Need in the Treatment of Early Breast Cancer

The Connection of Weight Gain to Recurrence of Disease in Early Breast Cancer

Adapting Breast Cancer Treatment Based on Initial Response

Management of Early Breast Cancer: Lessons From a Mentor

Reflections on a Patient With HER2-Positive Inflammatory Breast Cancer

Shared Decision-Making in Heart Failure

Optimizing Communication in Patients With IPF

February 28, 2023

Type 2 Diabetes With Obesity: Correcting the Biases

February 28, 2023

Recalling a Radical Shift in the Management of Patients With Type 2 Diabetes and Obesity

February 28, 2023

Type 2 Diabetes With Obesity: Reversing Disease Through Weight Loss

February 28, 2023

Better Strategies to Lessen Disparate Outcomes in Type 2 Diabetes With Obesity

February 28, 2023

Treatment of Type 2 Diabetes With Obesity: Defining the Cluster

February 28, 2023

Addressing Type 2 Diabetes by Addressing Obesity

January 30, 2023

Managing Patients With Early-Stage NSCLC: Always Bet With the Patient

January 30, 2023

Shifting the Perspective of Therapy Options in Early-Stage NSCLC

January 30, 2023

Early-Stage Non-Small Cell Lung Cancer: Mitigating the Rigors of Therapy

January 30, 2023

A Look Back at the Rapidly Evolving Treatment Landscape for Early-Stage NSCLC

January 30, 2023

How Opportunity and Mentorship Launched a Career in Thoracic Oncology

January 30, 2023

Early-Stage Non-Small Cell Lung Cancer: Advice to Oncologists Beginning Their Careers

January 30, 2023

Early-Stage Non-Small Cell Lung Cancer: Addressing the Imperfections

January 30, 2023

Thinking Big Picture in the Management of Patients With Early-Stage Non-Small Cell Lung Cancer

January 30, 2023

Witnessing Advances in Management Options for Patients With Early-Stage Non-Small Cell Lung Cancer

January 26, 2023

Analyzing Disparities in the Treatment of Mantle Cell Lymphoma

January 23, 2023

Recognizing the Many Faces of Mantle Cell Lymphoma

January 23, 2023

Tracing a Memorable Patient's Journey With Mantle Cell Lymphoma

January 19, 2023

Recognizing the Heterogenous Nature of Mantle Cell Lymphoma

January 19, 2023

A Patient Experience That Illustrates the Changing Treatment Landscape in Mantle Cell Lymphoma

January 18, 2023

An Impactful Patient Experience That Has Altered My Approach to Mantle Cell Lymphoma

January 12, 2023

Mantle Cell Lymphoma: Understanding the Ferocity of Relapse

January 6, 2023

Advanced and Metastatic Breast Cancer: A Shift in Thinking

January 6, 2023

Achieving a Long Duration of Response in Metastatic Breast Cancer Through Powerful Novel Therapies

January 6, 2023

A 'Stressed-Out' Healthcare Infrastructure Reveals Disparities in Availability of Care

January 6, 2023

An Impactful Experience With a Patient With Metastatic Breast Cancer

{{{header}}}

October 20, 2022

Should People Be More Worried About Long COVID?

Cure, Prevent, or Manage All Disease: The Chan Zuckerberg Initiative's Bold Plan Is Already Working

A Gutsy Plan to End Human Disease as We Know It

Michael Lewis on the Mirage That Is America's Public Health System

February 8, 2021

COVID-19 Modeling and the Path to Herd Immunity

January 5, 2021

We Will Need to Update COVID Vaccines, Expert Says

October 27, 2020

For COVID-19 Vaccines, ACIP Will Be a Critical Gatekeeper

October 9, 2020

FDA's Hahn to Topol: Decisions Will Be Made on Science Alone

September 9, 2020

Paul Offit's Biggest Concern About COVID Vaccines

Coronavirus in Context: Eric Topol Explains Emerging Research

January 30, 2020

Work in Healthcare? ZDoggMD Wants Your Voice to Be Heard

December 19, 2019

Heart Doc Writes About His 'Front-Row Seat' in Medicine

November 20, 2019

Inventor Manu Prakash: Everyone Deserves 'Access to the Microscopic World'

September 20, 2019

Navigating 'Nature' With Editor-in-Chief Magdalena Skipper

August 26, 2019

Dr Jen Gunter Is a Trailblazer for Truth (and the Vagina)

Author Dr Matt McCarthy Is Raising the Alarm on Superbugs

Deep Medicine: Restoring the Doctor-Patient Relationship

Fired Up About Climate Change and the Public Health

February 15, 2019

'Leading the Charge' on Racism, Sexism, Activism in Medicine

January 2, 2019

Is Confidence Overrated in Medical Practice?

{{{header}}}

High Hopes, Dashed Dreams: Progress in GI Cancers at ASCO

How Can We Make Medical Training Less 'Toxic'?

Transplant Centers Often Skip the Top Spot on the Kidney Waitlist

From ECCMID: New Anti-Viral and Bacterial Drugs of Interest

Doctors, Nurses Striking -- Is It Ethical?

COVID Boosters Effective, but Not for Long

COVID-19 Rebound: Is Treatment Worth It?

A Glimpse of Hope in Alzheimer's Disease?

Why the Hesitancy in Recommending Combination T3/T4 Therapy?

11 More Highlights From Digestive Disease Week 2023

9 Highlights From Digestive Disease Week 2023

Ketamine, Pain, and Depression: A Special Connection

Automated Insulin Delivery System, Not an Artificial Pancreas

Hemochromatosis: What We Should Have Learned About It

Prior-Authorization Woes? These Tools May Change the Game

Why I Will Recommend Mammograms at Age 40

HFpEF: New Guidelines Are Pertinent for Primary Care

ACC HFpEF Guidance: What to Know

How to Stay Healthy at 17,500 mph: A Space Doc's Insight

Top 5 Movement Disorders Highlights From AAN 2023

{{{header}}}

CMV: Focus on Clinician and Patient Awareness

September 24, 2021

Prevent VTE TV – The Latest Clinical Updates

October 30, 2020

Contemporary Topics in Pulmonary Hypertension

September 29, 2020

CGM-TV: Best Practices and Case Consults in Pediatric (T1D) and Adult (T2D) Patients

CME TV: Prevent VTE TV

December 19, 2019

Meningitis TV – Prevention Strategies in the Modern Era

Heart Failure TV: Managing Heart Failure in the Community

Functional GI Disorders TV: IBS-C, CIC, and IBS-D

October 30, 2018

Diagnosis TV: Timely Identification, Informed Patient Care in Infectious Diseases

CME TV: Contemporary Topics in Pulmonary Hypertension

Thrombosis TV: Treatment Across the Spectrum of Thromboembolic Disease

February 28, 2017

HPV-TV: Protection Today Against Cancer Tomorrow

September 20, 2016

Insulin TV: Individualized Management of Type 2 Diabetes

HIV-TV: Best Practices Along the Care Continuum

October 29, 2015

VTE TV: The Real Clinicians of VTE

Diabetes TV: Modern T2 Diabetes TV

PH TV Season 2: Focus on Expanding Care Options and Approaches

October 14, 2011

PainTV: Chronic Pain in America

{{{header}}}

Investigating an Infiltrative Cardiomyopathy: Can You Crack the Patient Cases?

Psych Conference Coverage 2023: Highlights of Pivotal Data for Schizophrenia Treatment

Individualizing Care for Patients with Lung Cancer: A Simulation to Test Your Skills

Simulation Station: Can You Effectively Manage These Patients With Lung Cancer?

From Diagnosis to Treatment and Referral: A Nephrology Patient Simulation

Immunotherapy in Non-Small Cell Lung Cancer

Hot Topics in Lung Cancer

Targeted Therapies 201: What's New and on the Horizon

Management of Small Cell Lung Cancer

Targeted Therapies 101 

Early-Stage and Locally Advanced Non-Small Cell Lung Cancer Management

PCSK9 Inhibitors: Tips and Tricks for Improving Access and Adherence

The Chemical Peel Masterclass

Ovarian Cancer Virtual Patient Case Simulation: How Do You Incorporate Maintenance Therapy?

A Roadmap to Elimination: Integrating Hepatitis C Diagnosis and Management Into Everyday Primary Care

Comprehensive Management of a Patient on Dialysis: A Patient Simulation

Tips and Tricks on Using Continuous Glucose Monitoring Data: The Experts Weigh In

Adjuvant Therapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer: Case Simulations

BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients

A Patient Simulation: Can You Diagnose These Patients With Painful Abscesses and Skin Nodules?